The Maudsley Prescribing Guidelines Series-The Maudsley Deprescribing Guidelines Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs

Mark Horowitz

Taal: Engels

Uitgever:

Wiley-Blackwell

EngelsPaperback978111982298115 februari 2024592 pagina's

Samenvatting

Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more.

Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so.

The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment.

This evidence-based handbook provides an overview of principles to be used in deprescribing. This is derived from fundamental scientific principles and the latest research on this topic, combined with emerging insights from clinical practice (including from patient experts).

Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released). The Maudsley Deprescribing Guidelines covers topics such as:

  • Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugs
  • Barriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation process
  • Distinguishing withdrawal symptoms, such as poor mood, anxiety, insomnia, and a variety of physical symptoms from symptoms of the underlying disorder that medication was intended to treat
  • The difference between physical dependence and addiction/substance use disorder
  • Explanation of why and how to implement hyperbolic tapering in clinical practice
  • Specific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approaches
  • Step-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for each drug, and guidance on how to tailor these to an individual
  • Troubleshooting issues which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse.

Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.



The Maudsley® Deprescribing Guidelines

Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more.

Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so.

The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment.

This evidence-based handbook provides an overview of principles to be used in deprescribing. This is derived from fundamental scientific principles and the latest research on this topic, combined with emerging insights from clinical practice (including from patient experts).

Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released). The Maudsley Deprescribing Guidelines covers topics such as:

  • Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugs
  • Barriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation process
  • Distinguishing withdrawal symptoms, such as poor mood, anxiety, insomnia, and a variety of physical symptoms from symptoms of the underlying disorder that medication was intended to treat
  • The difference between physical dependence and addiction/substance use disorder
  • Explanation of why and how to implement hyperbolic tapering in clinical practice
  • Specific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approaches
  • Step-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for each drug, and guidance on how to tailor these to an individual
  • Troubleshooting issues which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse.

Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.

Productspecificaties

Inhoud

Taal
en
Uitvoering
Paperback
Oorspronkelijke releasedatum
15 februari 2024
Aantal pagina's
592

Betrokkenen

Hoofdauteur

Mark Horowitz

Tweede Auteur

David M. Taylor

Hoofduitgeverij

Wiley-Blackwell

Informatie over de fabrikant

Fabrikant Naam
Wiley-vch Gmbh
Fabrikant Adres
Boschstrasse 12 - Weinheim
E-mailadres of online contactformulier van de fabrikant
product_safety@wiley.com

Overige kenmerken

Product breedte
168 mm
Product hoogte
31 mm
Product lengte
241 mm
Studieboek
Nee
Verpakking breedte
165 mm
Verpakking hoogte
38 mm
Verpakking lengte
242 mm
Verpakkingsgewicht
1127 g

EAN

EAN
9781119822981

Productveiligheid

Bekijk gegevens

Je vindt dit artikel in

Boek, ebook of luisterboek?

Boek

Beschikbaarheid

Leverbaar

Taal

Engels

Type boek

Paperback

Reviews

Gemiddeld 2,0 van de 5 sterren uit 1 reviews
Select-leden verdienen punten met hun reviews
heel hoofdstuk ontbreekt
25 maart 202550-59 jaarUtrechtHeeft dit artikel gekochtirboe

Inhoudelijk prima boek over afbouwen. Maar. Nu ik het boek van A tot Z lees kom ik er achter dat er een heel hoofdstuk ontbreekt! vanaf p 480 is er niets meer, terwijl het boek 553 pagina's zou moeten hebben. Een produktie fout dus. Hebben anderen dit ook? Wie kan ik het ontbrekend hoofdstuk vragen?

Kies gewenste uitvoering

Kies je uitvoering
Prijsinformatie en bestellenDe prijs van dit product is 55 euro en 99 cent. De adviesprijs is De adviesprijs is 58 euro en 14 cent..

De adviesprijs is De adviesprijs is 58 euro en 14 cent..

Uiterlijk 21 november in huis
Verkoop door bol
  • Prijs inclusief verzendkosten, verstuurd door bol

  • Ophalen bij een bol afhaalpunt mogelijk

  • 30 dagen bedenktijd en gratis retourneren via mijn bol

  • Dag en nacht klantenservice

  • Doordeweeks ook ’s avonds in huis

Bekijk retourvoorwaarden

Bekijk ook eens

Spontaan genezen

Aanraking is iets wonderlijks

Je kunt er wél iets aan doen

Aggression

Kopzorgen - Neurodiversiteit begrijpen

Anderen bekeken ook

Bekijk de hele lijst

Vaak samen gekocht

Bekijk de hele lijst